emerg edg estimate pt higher
rais ep pt cl mix maintain ep
guidanc recoveri china take time cl importantli see progress
across key market incl latam colgat total relaunch progress in-lin w/
expect acceler em key growth engin cl encourag howev
valuat look full price-to-earnings in-lin w/hpc group appropri hist
mix though improv em bright cl deliv modest upsid org sale
vs support acceler growth em put take
gm beat sg miss along help lower tax rate deliv
ep in-lin consensu result provid enough lift cl point
high-end org sale guidanc remain focus drive top-line growth
guidanc reiter competit spend remain risk cl guid call
org sale growth high-end previous given rang ii mid-
single-digit ep declin owe larg stepped-up invest support innov
expect seem reason w/street estimate toward high-end cl
rang market appropri focus top-line acceler howev
continu monitor risk hpc increas spend see note
hey spender invest risk global hpc ulvr pg rb expos link
takeaway confer call filorga ltm sale
 growth margin higher cl exist per care segment ep
impact accret ii skincar along w/natur premium
therapeut key adjac receiv invest cl attract categori
despit bp us share track channel pleas progress
untrack channel grow realli well iv em improv vs
 china progress expect w/cl optimist
sequenti improv co focus distribut network lat
fundament favor categori growth rate slightli posit though
cl cautiou post recent economic/polit develop eurasia/africa africa
acceler russia perform strong follow colgat total relaunch
toothpast market leader turkey
rais ep estim maintain hold rais ep estimate cl
mix quarter reiter ep guidanc cpg group fundament better
place see note find sweet strong start earn hpc/
beverag link howev ntm price-to-earnings cl share trade in-lin hpc peer
compar hist average premium view appropri given result
arguabl pedestrian past updat pt impli share
trade price-to-earnings reiter hold rate w/better opportun group top
pick chd/enr hpc
pleas see analyst certif import disclosur inform inform regard statu non-u analyst
page report
organ sale growth
oper margin declin bp
bp expans
ep lower due step invest
normal
price target ev/ebitda
ntm ebitda ev/ulfcf
bp top-line volum upsid rebound
bp oper margin upsid increment
product potenti commod tailwind
price target ev/ebitda
ntm ebitda ev/ulfcf
bp top-line volum downsid emerg market
bp margin pressur increas trade
promot unfavor move commod
price target ev/ebitda
ntm ebitda ev/ulfcf
colgat view potenti target larg
colgat oral care franchis among best
busi cpg market share growth
cl lever among coverag recoveri
emerg market
pleas see import disclosur inform page report
vs off-set higher sg
drive modest oi downsid in-lin ep
net sale growth flat low-single-digit reiter
organ sale high-end previous given rang
gross margin bp expans reiter expans yoy
advertis expect around rate
tax rate
cl maintain guidanc call
organ sale growth high end
previous state rang mid-
single-digit ep declin
mid-point in-lin w/street estimate
pleas see import disclosur inform page report
actualjef estimate million except incom expens incom compositionreport org sale bpsfx bp sale bpsmargin analysisgross bpsoper bpsebitda bpstax bp equiti research
colgat thesi chart
chart despit recent improv near-term macro
competit pressur em like keep cl org sale
growth well histor averag
chart compani face materi moder vs best-
in-class growth
chart expect cl oi growth remain pressur
near-to-intermedi term well growth
chart colgat margin enhanc impress
still expect slower growth due constrain top-line
commod fx invest
chart despit higher margin/fcf profil vs stapl peer
cl slow org sale increasingli uncertain outlook
weigh stock multipl view
chart cl valuat emb littl strateg halo busi
stall news report potenti suitor last report
quiet front
pleas see import disclosur inform page report
develop market growth market growth organ sale growth em/dm em/dm org sale growth em org sale growthdm org sale growthtot sale growth fx neutral oi growthorg sale growthfx neutral oi margin ebitda margin ebitda right axi gm left org salesgrowthebitda conversionul p/ecl vs peer metric clstapl peer ntm ev/ebitda vs peer nielsen result period end
chart cl four-week quarterli sale growth
nielsen xaoc jefferi note nielsen definit may differ compani defin
pleas see import disclosur inform page report
quarterli sale growth sale growth yoy sale growthtwo-year averag sale growthxaoc ccolgat palmol mixlatest soap-light cleaners-multi sale chg vs yageq sale chg vs yagavg eq price chg vs yagdollar share pt chg vs yageq share pt chg vs yag sold promo pt chg vs yag us market share dashboard
chart colgat sale growth vs industri growth left portfolio gain market share right
pleas see import disclosur inform page report
us track channel growth vs industryweight industri growthcl sale portfolio gain valu sharetrail averagetrail ltm averag colgat valuat look gener full
pleas see import disclosur inform page report
pleas see import disclosur inform page report
cl trade near long-term averag vs hpc
chart cl histor ntm price-to-earnings multipl vs
pleas see import disclosur inform page report
